Showing results 1 to 20 of 24
next >
| Issue Date | Title | Author(s) |
| 2021-10-09 | Hopeful dying? The meanings and practice of hope in palliative care family meetings. | Kirby, E; Broom, A; MacArtney, J; Lewis, S; Good, P |
| 2021-03 | Practice review: Evidence-based quality use of corticosteroids in the palliative care of patients with advanced cancer. | Hardy, J; Haywood, A; Rickett, K; Sallnow, L; Good, P |
| 2021-01-01 | Emotionally reflexive labour in end-of-life communication. | Olson, RE; Smith, A; Good, P; Neate, E; Hughes, C; Hardy, J |
| 2020 | Regular dosing compared with as-needed dosing of opioids for management of chronic cancer pain: systematic review and meta-analysis. | Edler-Buggy, S; Birtwistle, J; ElMokhallalati, Y; Kindl, K; Good, P; Bennett, MI |
| 2019-12-06 | Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: A double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD) | Good, P; Haywood, A; Gogna, G; Martin, J; Yates, P; Greer, R; Hardy, J |
| 2019-12-01 | Quality use of medicines: Oral corticosteroids in advanced cancer | Pinkerton, E; Good, P; Kindl, K; Richard, R; Fischer, A; Hardy, JR |
| 2019-10-01 | The Impact of Provision of Professional Language Interpretation on Length of Stay and Readmission Rates in an Acute Care Hospital Setting | Abbato, S; Greer, R; Ryan, J; Vayne-Bossert, P; Good, P |
| 2019-09-12 | Methotrimeprazine versus haloperidol in palliative care patients with cancer-related nausea: a randomised, double-blind controlled trial. | Hardy, JR; Skerman, H; Philip, J; Good, P; Currow, DC; Mitchell, G; Yates, P |
| 2019-09-01 | Harms From Haloperidol for Symptom Management in Palliative Care—a Post Hoc Pooled Analysis of Three Randomized Controlled Studies and Two Consecutive Cohort Studies | Matsuoka, H; Agar, M; Vandersman, Z; Good, P; Fazekas, B; Brown, L; Hardy, J; Weil, J; Currow, DC |
| 2019-07-01 | Palliative care in cirrhosis with decompensation | Plunkett, A; Mortimore, M; Good, P |
| 2019-03-04 | Managing diabetes at the end of life–a retrospective chart audit of two health providers in Queensland, Australia | Alqabandi, N; Haywood, A; Kindl, K; Khan, S; Good, P; Hardy, J |
| 2019-02-20 | Systemic corticosteroids for the management of cancer-related breathlessness (dyspnoea) in adults | Haywood, A; Duc, J; Good, P; Khan, S; Rickett, K; Vayne-Bossert, P; Hardy, JR |
| 2019-02-01 | Why is optimisation of antimicrobial use difficult at the end of life? | Broom, J; Broom, A; Good, P; Lwin, Z |
| 2019-01-02 | The pattern and timing of changes in preferred place of death for patients admitted to a community specialist palliative care service | Win, MM; Fischer, A; Good, P |
| 2016-03-01 | Locating care at the end of life: Burden, vulnerability, and the practical accomplishment of dying | Macartney, JI; Broom, A; Kirby, E; Good, P; Wootton, J; Adams, J |
| 2015-09-01 | The effect of methylphenidate on fatigue in advanced cancer: An aggregated N-of-1 trial | Mitchell, GK; Hardy, JR; Nikles, CJ; Carmont, SAS; Senior, HE; Schluter, PJ; Good, P; Currow, DC |
| 2015-01-01 | On resilience and acceptance in the transition to palliative care at the end of life | MacArtney, JI; Broom, A; Kirby, E; Good, P; Wootton, J; Yates, PM; Adams, J |
| 2014-02-01 | The troubles of telling: Managing communication about the end of life | Broom, A; Kirby, E; Good, P; Wootton, J; Adams, J |
| 2014-01-01 | Medical specialists' motivations for referral to specialist palliative care: A qualitative study | Kirby, E; Broom, A; Good, P; Wootton, J; Adams, J |
| 2014-01-01 | Families and the transition to specialist palliative care | Kirby, E; Broom, A; Good, P; Wootton, J; Adams, J |
